Urology
Volume 67, Issue 6 , Pages 1253-1256 , June 2006

Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: A prospective analysis

Received 23 August 2005 ,Accepted 1 December 2005.

References 

  1. Bolla M , Gonzalez D , Warde P , et al.   Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin . N Engl J Med . 1997;337:295–300
  2. Kupelian P , Buchsbaum J , Elshaikh M , et al.   Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above . Cancer . 2002;95:2302–2307
  3. Ward J , Slezak J , Blute M , et al.   Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing (15-year outcome) . BJU Int . 2005;95:751–756
  4. Bader P , Burkhard F , Markwalder R , et al.   Disease progression and survival of patients with positive lymph nodes after radical prostatectomy (is there a chance of cure?) . J Urol . 2003;169:849–854
  5. Thompson I , Tangen C , Basler J , et al.   Impact of previous local treatment for prostate cancer on subsequent metastatic disease . J Urol . 2002;168:1008–1012
  6. Coen J , Zietman A , Thakral H , et al.   Radical radiation for localized prostate cancer (local persistence of disease results in a late wave of metastases) . J Clin Oncol . 2002;20:3199–3205
  7. Johansson J , Holmberg L , Johansson S , et al.   Fifteen-year survival in prostate cancer (a prospective, population-based study in Sweden) . JAMA . 1997;277:467–471
  8. Hanks G , Pajak T , Porter A , et al.   Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate (the Radiation Therapy Oncology Group protocol 92-02) . J Clin Oncol . 2004;22:3972–3978
  9. Bolla M , Collette L , Blank L , et al.   Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study) (a phase III randomised trial) . Lancet . 2002;360:103–106
  10. Kattan M , Stapleton A , Wheeler T , et al.   Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma . Cancer . 1997;79:528–537
  11. Clark P , Peereboom D , Dreicer R , et al.   Phase II trial of neoadjuvant estramustine phosphate and etoposide plus radical prostatectomy for locally advanced prostate cancer . Urology . 2001;57:281–285
  12. Dreicer R , Magi-Galluzzi C , Zhou M , et al.   Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancer . Urology . 2004;63:1138–1142
  13. Hussain M , Smith D , El-Rayes B , et al.   Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locally advanced prostate cancer . Urology . 2003;61:774–780

PII: S0090-4295(05)01735-8

doi: 10.1016/j.urology.2005.12.003

Urology
Volume 67, Issue 6 , Pages 1253-1256 , June 2006

Article Tools

* Image Usage & Resolution